These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9531240)

  • 1. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 3. Dangers, myths, controversy. Sublingual nifedipine for hypertensive crisis.
    Kaufman SE; Schneider EF
    JAAPA; 2000 Mar; 13(3):67-8, 71-4, 80. PubMed ID: 11503405
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of calcium antagonists (sublingually) in the treatment of hypertensive crises].
    Shcherban' NN; Pakhomova SP; Kalenskiĭ VKh; Podstavnaia LI
    Klin Med (Mosk); 1988 Apr; 66(4):37-9. PubMed ID: 3398448
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of antihypertensive drugs in pregnancy].
    Tsaava F; Shonia R
    Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-acting nifedipine.
    Gauthier B; Trachtman H
    Pediatr Nephrol; 1997 Dec; 11(6):786-7. PubMed ID: 9438668
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the safety of short-acting nifedipine in children with hypertension.
    Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
    Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel antagonists: morbidity and mortality--what's the evidence?
    Straka RJ; Swanson AL; Parra D
    Am Fam Physician; 1998 Apr; 57(7):1551-60. PubMed ID: 9556644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the hypotensive effects of finoptin and corinfar after their sublingual administration].
    Kolesova MA; Orlov VM
    Klin Med (Mosk); 1988 Feb; 66(2):38-41. PubMed ID: 3286995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is there a risk in treatment of hypertension with nifedipine?].
    Düsing R
    Internist (Berl); 1996 Sep; 37(9):939-41. PubMed ID: 8964691
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions to short-acting nifedipine in hypertensive crises.
    Spizzirri F; Rahman R
    Pediatr Nephrol; 1999 May; 13(4):366. PubMed ID: 10454793
    [No Abstract]   [Full Text] [Related]  

  • 15. The nifedipine scare in hypertension: fact or fiction.
    Gambhir DS
    Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical features and up-to-date therapy of hypertensive emergencies].
    Meyer FP
    Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertensive urgencies: how to give a low dose of short-acting nifedipine.
    Bloomfield RL; Carter J
    Geriatrics; 1996 Sep; 51(9):10. PubMed ID: 8814107
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
    Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A
    Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.